浙江圣达生物药业股份有限公司关于完成工商变更登记的公告

Group 1 - The company has completed the registration of changes in its business license and has obtained a new business license from the Zhejiang Provincial Market Supervision Administration [2] - The new business license indicates that the registered capital of the company is 189,026,240 yuan, and it is classified as a listed other joint-stock company [2] - The company’s operational scope includes the production of pharmaceuticals, feed additives, food additives, and hazardous chemicals, among other activities [2] Group 2 - The company held meetings on November 27, 2025, and December 15, 2025, to approve the cancellation of the supervisory board and amendments to the company’s articles of association [1] - The company has published relevant announcements regarding these changes in the Shanghai Securities Journal and on the Shanghai Stock Exchange website [1]